Adverse Drug Reactions in Older Adults, explained for the bedside and the exam

What the concept actually says

An adverse drug reaction in an older adult is rarely the reaction described in the drug reference. Anticholinergics, benzodiazepines and NSAIDs sit at the top of the list because they are prescribed often, interact with age-related physiology badly, and their harm shows up as something the ward would otherwise call a geriatric syndrome rather than a drug event. The presenting sign is often a fall, not a rash, not a documented allergic reaction, not the clean cause-and-effect a student expects.

This matters because a fall gets triaged as a fall. Someone orders an X-ray, checks for a hip fracture, documents a mechanical trip. The medication list sits untouched unless someone deliberately looks at it. Anticholinergics blur vision and slow reaction time. Benzodiazepines sedate and reduce postural control. NSAIDs raise blood pressure, worsen renal function, and in an older adult already on a diuretic or ACE inhibitor, that renal hit compounds fast. None of that reads as 'adverse drug reaction' on a chart unless a nurse names it as one.

The clinical reasoning behind it

Older adults have reduced hepatic first-pass metabolism, lower glomerular filtration rate, and a higher proportion of body fat to lean mass. A benzodiazepine that clears in hours in a 40-year-old can linger for a day or more in an 80-year-old. That prolonged half-life means a dose given at bedtime is still active and sedating well into the next morning, exactly when a patient gets up to use the bathroom unassisted.

Anticholinergic burden is cumulative. A patient rarely takes one anticholinergic in isolation, they accumulate across an antihistamine for sleep, an overactive bladder medication, and an antidepressant with anticholinergic properties, and each adds to a cognitive and motor load that no single prescriber sees in full. NSAIDs reduce renal blood flow through prostaglandin inhibition, and in a dehydrated or diuretic-treated older adult that can tip stable renal function into acute kidney injury within days, which itself raises drug levels of anything renally cleared and starts a second cascade.

The Beers criteria exist because this pattern is predictable, not incidental. It is a list built from documented harm in this population, and it flags exactly these three classes as high-risk first-line choices to avoid or use with caution.

Applying it under time pressure

On a busy shift, the practical move is to treat any new fall, new confusion or new dizziness in a patient over 65 as medication-related until proven otherwise. Pull the medication administration record before you pull the incident report template. Look specifically for anticholinergics, benzodiazepines and NSAIDs, check when the last dose was given relative to the event, and check renal function trend if an NSAIDor a renally cleared drug is on the list.

Report findings to the provider with the mechanism attached, not just the observation. 'Patient fell at 0600, received lorazepam at 2200' is more actionable than 'patient fell, will monitor.' That framing is what gets a medication reviewed rather than a fall risk band added without addressing the cause.

Common misconceptions

The first misconception is that adverse drug reactions look dramatic, hives, anaphylaxis, a clear temporal link to a new drug. In older adults they usually look like a fall, new confusion, or a slow functional decline over days, which makes them easy to attribute to age itself rather than to a prescription.

The second is that a drug the patient has taken safely for years cannot suddenly cause harm. Renal function declines gradually, and a stable dose of an NSAID or benzodiazepine can become toxic as GFR drops without any dose change at all, so 'they've always been on this' is not reassurance.

The third is that Beers criteria means a drug is banned. It means the risk-benefit calculation shifts and requires closer monitoring or an alternative, not that the drug can never be used.

Practice scenarios

An 82-year-old on chronic diazepam for anxiety is found on the floor beside the bed at 0530, no visible injury, slightly drowsy. The exam-correct first action is not a full body assessment alone, it is a full body assessment plus a review of when the last diazepam dose was given and whether the dose or timing needs provider notification.

A 76-year-old with osteoarthritis started on ibuprofen three days ago now has a creatinine that has risen from baseline and new mild confusion. The reasoning chain the NCLEX wants: NSAID reduces renal perfusion, renal function drops, drugs cleared renally accumulate, confusion follows. The nursing priority is holding the NSAID and notifying the provider, not simply reorienting the patient.

A patient on diphenhydramine for sleep plus an antihistamine plus oxybutynin for bladder control presents with dry mouth, blurred vision and a near-fall reaching for a walker. This is anticholinergic burden across three drugs, and it is a medication reconciliation problem before it is a fall-precautions problem.

Key takeaways

Anticholinergics, benzodiazepines and NSAIDs account for most adverse drug reactions in older adults, and a fall is frequently the first visible sign rather than a classic drug reaction.

Reduced renal clearance and prolonged drug half-life mean stable doses can become toxic without any prescribing change, so a new symptom always warrants a medication review, not just an age-related explanation.

Beers criteria flags these classes for closer scrutiny, not automatic avoidance, and the nursing role is to connect the fall or confusion back to the drug list before it gets filed as an unrelated event.